The Role of Tumour Metabolism in Cisplatin Resistance

Cisplatin is a chemotherapy drug commonly used in cancer treatment. Tumour cells are more sensitive to cisplatin than normal cells. Cisplatin exerts an antitumour effect by interfering with DNA replication and transcription processes. However, the drug-resistance properties of tumour cells often cau...

Full description

Bibliographic Details
Main Authors: Lude Wang, Xiaoya Zhao, Jianfei Fu, Wenxia Xu, Jianlie Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.691795/full
_version_ 1818407255851139072
author Lude Wang
Xiaoya Zhao
Jianfei Fu
Wenxia Xu
Jianlie Yuan
author_facet Lude Wang
Xiaoya Zhao
Jianfei Fu
Wenxia Xu
Jianlie Yuan
author_sort Lude Wang
collection DOAJ
description Cisplatin is a chemotherapy drug commonly used in cancer treatment. Tumour cells are more sensitive to cisplatin than normal cells. Cisplatin exerts an antitumour effect by interfering with DNA replication and transcription processes. However, the drug-resistance properties of tumour cells often cause loss of cisplatin efficacy and failure of chemotherapy, leading to tumour progression. Owing to the large amounts of energy and compounds required by tumour cells, metabolic reprogramming plays an important part in the occurrence and development of tumours. The interplay between DNA damage repair and metabolism also has an effect on cisplatin resistance; the molecular changes to glucose metabolism, amino acid metabolism, lipid metabolism, and other metabolic pathways affect the cisplatin resistance of tumour cells. Here, we review the mechanism of action of cisplatin, the mechanism of resistance to cisplatin, the role of metabolic remodelling in tumorigenesis and development, and the effects of common metabolic pathways on cisplatin resistance.
first_indexed 2024-12-14T09:24:56Z
format Article
id doaj.art-0c06904982564f0f8389db026d94c918
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-12-14T09:24:56Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-0c06904982564f0f8389db026d94c9182022-12-21T23:08:13ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2021-06-01810.3389/fmolb.2021.691795691795The Role of Tumour Metabolism in Cisplatin ResistanceLude Wang0Xiaoya Zhao1Jianfei Fu2Wenxia Xu3Jianlie Yuan4Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, ChinaCentral Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, ChinaDepartment of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, ChinaCentral Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, ChinaDepartment of Neurosurgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, ChinaCisplatin is a chemotherapy drug commonly used in cancer treatment. Tumour cells are more sensitive to cisplatin than normal cells. Cisplatin exerts an antitumour effect by interfering with DNA replication and transcription processes. However, the drug-resistance properties of tumour cells often cause loss of cisplatin efficacy and failure of chemotherapy, leading to tumour progression. Owing to the large amounts of energy and compounds required by tumour cells, metabolic reprogramming plays an important part in the occurrence and development of tumours. The interplay between DNA damage repair and metabolism also has an effect on cisplatin resistance; the molecular changes to glucose metabolism, amino acid metabolism, lipid metabolism, and other metabolic pathways affect the cisplatin resistance of tumour cells. Here, we review the mechanism of action of cisplatin, the mechanism of resistance to cisplatin, the role of metabolic remodelling in tumorigenesis and development, and the effects of common metabolic pathways on cisplatin resistance.https://www.frontiersin.org/articles/10.3389/fmolb.2021.691795/fulltumour metabolismcisplatinresistanceDNA damage repairROS
spellingShingle Lude Wang
Xiaoya Zhao
Jianfei Fu
Wenxia Xu
Jianlie Yuan
The Role of Tumour Metabolism in Cisplatin Resistance
Frontiers in Molecular Biosciences
tumour metabolism
cisplatin
resistance
DNA damage repair
ROS
title The Role of Tumour Metabolism in Cisplatin Resistance
title_full The Role of Tumour Metabolism in Cisplatin Resistance
title_fullStr The Role of Tumour Metabolism in Cisplatin Resistance
title_full_unstemmed The Role of Tumour Metabolism in Cisplatin Resistance
title_short The Role of Tumour Metabolism in Cisplatin Resistance
title_sort role of tumour metabolism in cisplatin resistance
topic tumour metabolism
cisplatin
resistance
DNA damage repair
ROS
url https://www.frontiersin.org/articles/10.3389/fmolb.2021.691795/full
work_keys_str_mv AT ludewang theroleoftumourmetabolismincisplatinresistance
AT xiaoyazhao theroleoftumourmetabolismincisplatinresistance
AT jianfeifu theroleoftumourmetabolismincisplatinresistance
AT wenxiaxu theroleoftumourmetabolismincisplatinresistance
AT jianlieyuan theroleoftumourmetabolismincisplatinresistance
AT ludewang roleoftumourmetabolismincisplatinresistance
AT xiaoyazhao roleoftumourmetabolismincisplatinresistance
AT jianfeifu roleoftumourmetabolismincisplatinresistance
AT wenxiaxu roleoftumourmetabolismincisplatinresistance
AT jianlieyuan roleoftumourmetabolismincisplatinresistance